Pregabalin (Lyrica)
Is It Right for You?
A complete guide to Pregabalin (Lyrica) — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Pregabalin (Lyrica)?
Pregabalin, marketed as Lyrica, is a gabapentinoid anticonvulsant and analgesic agent available in capsules (25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg) and an oral solution (20 mg/mL). It is used across three principal clinical areas: neuropathic pain, epilepsy, and generalised anxiety disorder (GAD).
Pregabalin is structurally related to gabapentin but demonstrates more predictable and linear pharmacokinetics, more rapid onset of action, and superior bioavailability — allowing for twice-daily rather than three-times-daily dosing in most indications.
Since April 2019, pregabalin has been reclassified as a Schedule 3 Controlled Drug (CD) in the UK, due to evidence of misuse, diversion, and dependency. It requires prescriptions to be handwritten (or issued via approved electronic systems), dispensed only against an original valid prescription, and cannot be repeated without a new prescription. A clinician must carefully assess dependency risk before prescribing.
What Conditions Is Pregabalin Used For?
Pregabalin is indicated for:
including diabetic peripheral neuropathy, post-herpetic neuralgia (shingles pain), and chemotherapy-induced neuropathy
including pain from spinal cord injury
as adjunctive therapy in adults with partial onset seizures with or without secondary generalisation
Pregabalin carries a recognised risk of abuse, misuse, and physical dependency — including in patients without a prior history of substance misuse. It should be prescribed at the lowest effective dose for the shortest necessary duration. The decision to prescribe must include an explicit discussion of dependency risk, and patients should be monitored for signs of overuse or escalating doses.
How Does Pregabalin Work?
Despite being structurally related to gamma-aminobutyric acid (GABA), pregabalin does not bind to GABA receptors, enhance GABA signalling, or act via a GABAergic mechanism. Its principal mechanism is:
Alpha-2-delta (α2δ) subunit binding: Pregabalin binds with high affinity to the α2δ subunit of voltage-gated calcium channels located on presynaptic nerve terminals throughout the central and peripheral nervous systems. These channels are upregulated in damaged or sensitised neurons — as occurs in neuropathic pain states and in areas of epileptic activity.
Reduction of neurotransmitter release: By binding to the α2δ subunit, pregabalin reduces calcium influx into presynaptic terminals, selectively attenuating the release of excitatory neurotransmitters — including glutamate, substance P, and norepinephrine — from hyperexcitable neurons. It does not affect normal neuronal transmission significantly, which explains its relatively selective action on pathologically sensitised pain pathways and epileptic foci.
In neuropathic pain: Abnormal nociceptive neuron firing (central sensitisation) drives the burning, shooting, and allodynic pain of neuropathy; pregabalin's dampening of calcium-channel-dependent excitatory neurotransmitter release reduces this aberrant signalling.
In GAD: The anxiolytic mechanism is less fully characterised but is believed to involve reduction of excitatory neurotransmitter release in amygdala and cortical circuits involved in the anxiety response, producing anxiolytic effects comparable to benzodiazepines but without direct GABAergic receptor activity.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Can be taken with or without food. Food has no significant effect on pregabalin absorption.
Take doses at evenly spaced intervals. Twice-daily dosing should ideally be taken approximately 12 hours apart to maintain stable plasma levels.
Do not stop suddenly. Abrupt withdrawal can cause seizures (including in patients not prescribed pregabalin for epilepsy), anxiety, insomnia, nausea, and sweating — hallmarks of physical dependency. Taper doses over a minimum of 1 week; longer tapers are required for higher doses and longer durations of use.
Avoid alcohol. Alcohol significantly amplifies pregabalin's sedative and CNS-depressant effects and increases the risk of respiratory depression.
Report the need for dose escalation. If you find yourself needing increasing doses for the same effect, inform your clinician promptly — this may indicate the development of tolerance or dependency.
Side Effects of Pregabalin
Most side effects are mild and resolve on their own. Serious side effects are rare but require immediate medical attention.
- Dizziness and somnolence --- the most frequently reported side effects; particularly at initiation and following dose increases
- Ataxia (unsteadiness) and impaired coordination
- Weight gain
- Blurred or double vision
- Dry mouth
- Peripheral oedema (ankle swelling)
- Fatigue and cognitive impairment (difficulty concentrating, memory issues)
- Euphoria --- a recognised effect that underlies pregabalin's misuse potential
- Respiratory depression --- particularly when combined with opioids, benzodiazepines, or other CNS depressants; potentially fatal; risk is greatest at initiation of concurrent therapy
- Severe allergic reactions --- including anaphylaxis and angioedema (swelling of the face, mouth, and throat); requires immediate emergency care
- Suicidal ideation --- as with all anticonvulsants, pregabalin carries a class-level increased risk of suicidal thoughts; monitor closely, particularly in the first weeks of treatment
- Rhabdomyolysis --- rare; severe muscle breakdown with elevated creatine kinase; presents with muscle pain, weakness, and dark urine
- Renal failure --- rare; pregabalin-associated acute kidney injury has been reported
Concurrent use of pregabalin and opioid analgesics (including codeine, tramadol, morphine, oxycodone) significantly increases the risk of respiratory depression and fatal drug-drug interaction. This combination is responsible for a disproportionate number of drug-related deaths in the UK. It must be prescribed only after careful benefit-risk assessment, at the lowest necessary doses, with clear patient counselling.
Drug Interactions
Pregabalin may interact with other medications, including strong CNS depressants. Always inform your clinician about all medications you are taking.
additive CNS depression and respiratory depression; risk of fatal respiratory compromise; avoid combination or use at significantly reduced doses with close monitoring.
significantly potentiates pregabalin's CNS-depressant effects; advise abstinence during treatment.
clinical pharmacokinetic studies showed additive impairment of cognitive and gross motor function; prescribers should be aware.
reduce pregabalin absorption by approximately 20% when taken simultaneously; take pregabalin at least 2 hours apart from antacids.
Important Warnings
Pregabalin is a Schedule 3 Controlled Drug. Physical dependency can develop, and misuse for recreational euphoric effects is well documented. It must be prescribed at the lowest effective dose for the shortest necessary duration. Patients with a history of substance misuse (including alcohol) are at higher risk of dependency and should be assessed carefully before prescribing.
The combination of pregabalin with opioids is a leading cause of preventable drug-related death in the UK. This combination must only be used when clearly clinically indicated, at the lowest effective doses, with explicit patient counselling about the risk and with regular review.
Abrupt or rapid discontinuation of pregabalin causes significant withdrawal symptoms including agitation, insomnia, anxiety, nausea, and seizures. Any dose reduction plan must be gradual, individually tailored, and clinician-supervised — particularly after prolonged or high-dose use.
Pregabalin is renally excreted; dose reduction proportional to eGFR is mandatory in patients with renal impairment to prevent drug accumulation and toxicity. Always disclose renal function to your clinician.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Pregabalin FAQs
Doxycycline should be avoided during pregnancy where possible. While most of the established risk relates to the second and third trimesters (tooth staining and bone effects on the foetus), clinicians generally avoid doxycycline throughout pregnancy and will prescribe a safer alternative. Always inform your clinician if you are pregnant or trying to conceive.
Desloratadine is the active metabolite of loratadine – meaning loratadine is converted into desloratadine by the liver after ingestion. Desloratadine works more directly and at a lower dose than loratadine. It also has a slightly longer duration of action. Both are effective, non-sedating antihistamines, but desloratadine is generally considered the more potent of the two.
Desloratadine is classified as a non-sedating antihistamine and is significantly less likely to cause drowsiness than first-generation antihistamines. However, a small number of people may experience mild fatigue or drowsiness, particularly when first starting the medication. If this occurs, avoid driving or operating machinery until you know how it affects you.
Yes, phenoxymethylpenicillin is considered one of the safest antibiotics to use during pregnancy and is a preferred choice for treating streptococcal infections in pregnant women. Always inform your clinician that you are pregnant before starting any medication.
Yes. A licensed clinician can assess your symptoms via a telehealth consultation and prescribe phenoxymethylpenicillin if it is clinically appropriate. Prescriptions are typically sent to your preferred pharmacy the same day, often within minutes of your consultation.